• One-Stop CAR-T Development
  • Biomarker Identification & Selection
  • ScFv Generation
  • CAR Design & Construction
    • CHAR Construction
  • CAR-T Gene Packaging & Delivery
  • Replication-Competent Virus Testing
  • CAR Cell In Vitro Assay
  • CAR-T Preclinical In Vivo Assay
  • IND Development for CAR-T Cell Therapy
  • GMP Production for CAR-T Products
  • CAR Clinical Trial
  • One-Stop Canine CAR-T Development
  • One-Stop mRNA CAR-T Development
  • TRAC-CAR-T Cell Development
  • Modular CAR-T Cell Generation
  • One-Stop Silence™ CAR-T Cell Development
  • Vaccine Boosting CAR-T Cell Therapy
  • STAb-T Cell Development
  • Anti-HIV CAR Cell Development
  • T Cell Activity Modulator Discovery
  • T Cell Programming
  • Virus Specific T Cell (VST) Development
  • Antibody-Coupled T Cell Receptor (ACTR) Development
  • Organoid-induced hPSC-original T Cell Differentiation
  • γδ T Cell Engineering
  • Next-Generation CAR-T Development
  • Antigen Presenting Cell Targeting Enhancement
• TCR-Like Antibody Development
  • MHC/Peptide Complex Production
  • TCR-Like Antibody Discovery
  • TCR-Like Antibody Affinity Characterization
  • TCR-Like CAR Construction & Evaluation
• TIL Therapy Development
  • One-Stop TIL Development
  • Special TIL Therapy Development
  • TIL based Antibody Discovery
• One-Stop CAR-NK Development
  • One-Stop CAR-NKT Development
  • One-Stop UniCAR-NK Development
  • iPSC derived CAR-NK Development
  • One-Stop TCR-NK Development
  • NK Cell Genetic Engineering
    • TCR-NK: TCR engineered NK Cell Development
  • NK Cell Expansion
  • CAR-NK Enhancement Platforms
  • NK Cell Manufacturing
• One-Stop Solid Tumor Targeting CAR-T Development
  • CAR-T Development Combat Poor Trafficking & Physical Barrier
    • CAR-T Development through Bypass Systemic Trafficking
    • CAR-T Development through Chemokine-Axis Matching
    • CAR-T Development with ECM & Stroma Disruption
  • CAR-T Development Combat Hypoxia & Metabolic Stress
    • Metabolic Fitness Enhanced CAR-T Cell Engineering
    • CAR-T Development by Metabolic Reprogramming
    • CAR-T Development by Targeting Metabolic Pathway
  • Safety & Control Development
    • CAR-T Development with Dual ON/OFF Switch
    • CAR-T Development with Adapter Switch
    • CAR-T Development with ON Switch
    • CAR-T Development with OFF Switch
  • CAR-T Development Combat Immuno-Suppressive TME
    • Target Immune Checkpoint
    • Target Cytokine & Chemokine Milieu
    • Target Immunosuppressive Cell
    • CAR-T derived Exosome Combat Immuno-Suppressive TME
  • CAR-T Development Combat Antigen Heterogeneity & Escape
    • CAR-T Development by Epigenetic/Pharmacologic Antigen Modulation
    • Dual/Tandem CAR Development
    • CAR-T Development by Preventing Antigen Stripping
    • AdCAR-T Development
    • Signaling Boosted CAR-T Development
  • CAR-T Combination Development
    • TRUCK CAR-T Development
    • Hyaluronidase & CAR-T Development
    • mRNA Vaccine & CAR-T Development
• CIK Therapy Development
  • One-Stop CIK Therapy Development
  • CIK Therapy Improvement
• One-Stop TCR-T Development
  • TCR Biomarker Identification & Selection
  • TCR Generation & Optimization
  • TCR Design & Construction
  • TCR Gene Packaging & Delivery
  • TCR In Vitro Assay
  • TCR-T Preclinical In Vivo Assay
  • TCR Clinical Application
  • TCR Analysis
    • TCR Clonality Assessment Service
  • TCR Tetramerization Construction
  • ScFv-TCR T Cell Therapy Development
  • AbTCR Development
  • Bispecific TCR Development
  • CER Development
  • AI-driven TCR Single-Cell Screening
  • TRuC-T Cell Development
    • One-Stop Core TRuC-T Development
    • "Armored" & TME Penetration TRuC-T Development
  • High-Affinity TCR-T Development
  • TAC-T Cell Development
    • One-Stop Autologous TAC-T Development
    • Allogeneic TAC-T Development
    • Armored & Combination TAC-T Development
• Next-Gen CAR-T Toxicity Management Solutions
  • CRS Management Solutions
    • CRS Research Model Development
  • ICANS Management Solutions
  • Infection Management Solutions
  • IEC-HS Management Solutions
  • ICAHT Management Solutions
  • Coagulopathy Management Solutions
  • TIAN Management Solutions
  • On-target/Off-tumor Toxicologic Effect Analysis
• Artificial T Cell-Stimulating Platform Development
  • Artificial T Cell Stimulator Development
  • Hydrogel-based Artificial T Cell-Stimulating Platform Development
  • DNA-based Artificial T Cell-Stimulating Platform Development
  • Alternative Polymeric-based Artificial T Cell-Stimulating Platform Development
  • Soluble Artificial T Cell-Stimulating Platform Development
  • Artificial T Cell-Stimulating System Function Characterization
• One-Stop CAR-B Development
• In Vivo CAR-T Development
  • Comprehensive In Vivo CAR-T Development
  • In Vivo B Cell Engineering
  • In Vivo CAR-NK Cell Engineering
  • In Vivo CAR-M Cell Engineering
  • In Vivo PBMC Engineering
• Functional CAR-T Discovery & Development
  • High-Throughput Functional CAR-T Screening
  • Functional CAR-T Optimization
  • Advanced Functional CAR-T Data Analysis & Validation
• One-Stop CAR-MA Development
• One-Stop Allogeneic Cell Development
  • Allogeneic CAR-T Development
  • Allogeneic TCR-T Development
  • Allogeneic CAR-NK Development
  • Allogeneic CAR/TCR Cell Design & Engineering
  • Other Allogeneic Cell Development
• Metabolic Enhanced CAR-T Development
  • CD8⁺ T Cell Metabolic Analysis
  • CD8⁺ T Cell Metabolic Modulation
  • Combination Immunotherapy Development
  • Metabolism targeted Therapeutic Evaluation
• One-Stop CAR-Monocyte Development
• Cancer Vaccine Development
  • Cancer Vaccine Discovery
  • Cancer Vaccine Engineering
  • Cancer Vaccine Analytical Characterization
  • Cancer Vaccine In Vivo Assessment
  • Cancer Vaccine GMP Manufacturing
  • Dendritic Cell Vaccine Development
• CAR-T Therapy Development for Non-Cancer Applications
• One Stop CAR-Treg Development
  • CAR-Treg Development
• Immune Genotyping
  • HLA Typing
  • KIR Typing
  • HLA Testing
  • Dog DLA Genotyping
  • Guinea Pig GPLA Genotyping
  • Mouse H2 Genotyping
  • Rabbit RLA Genotyping
  • Rat RT1 Genotyping
  • Rhesus Macaque MHC Genotyping
• Precision DC Vaccine Development
  • Ex Vivo DC Vaccine Design & Optimization
  • In Vivo DC Targeted Drug Delivery Development
• Preclinical Trial-on-Chip Powered CAR-T Development
  • Preclinical Trial-on-Chip Infrastructure & Model Development
  • Dynamic CAR-T Efficacy Validation
  • Safety & Toxicity Forecasting
• First-in-Human CAR-T Acceleration
  • First-in-Human Strategy Design for CAR-T Development
    • Adaptive First-in-Human Dose-Escalation Protocol Design for CAR-T Development
    • Safety Stopping Rule & Dose-Limiting Toxicity Criteria Definition for CAR-T Development
    • Bridging Therapy & Pre-Infusion Management Strategy Design for CAR-T Development
    • Integrated PK/PD & CK Sampling Plan Design for CAR-T Development
  • Real-Time Safety Monitoring & Crisis Readiness Solution Design
    • CRS/ICANS Management Solution Design
    • Daily Investigator Assessment & SRC Coordination Design
  • Data driven Dose Escalation & Translational Analysis for CAR-T Development
    • Real-Time Bioanalysis for Cellular Kinetic
    • Adaptive Safety Review & Recommendation
• Other Services
  • Rapid Plant based Antibody Production
  • Efficient & High-Quality Immunoadhesin Production
  • UV-Activated Site-Specific Antibody Labeling
  • Automated Protein Synthesis & Screening
  • GMP-Compliant Active Immunocyte Production

Creative Biolabs has a tradition of commitment. To achieve efficient execution and regulatory approval, we offer careful considerations of your program for the development of a cellular or gene therapy product – now and in the future.

• TCR-T Development Solutions
• CAR-T Development Solutions

• Process Development
• Analytical Development
• CAR-T Plasmid CDMO
  • RG CAR-T Plasmid DNA Manufacturing
  • GMP-like CAR-T Plasmid Manufacturing
  • GMP CAR-T Plasmid DNA Manufacturing
• CAR Viral Vector CDMO
  • RG CAR-T Virus Manufacturing
  • GMP-like CAR-T Virus Manufacturing
  • GMP CAR-T Virus Manufacturing
  • cGMP CAR-T AAV Production
  • cGMP CAR-T Lentivirus Production
  • cGMP CAR-T Retrovirus Production
  • Custom cGMP CAR-T Virus Production
• CAR IVT RNA & LNP Manufacturing
  • RG CAR-T mRNA Manufacturing
  • GMP-like CAR-T mRNA Manufacturing
  • GMP CAR-T mRNA Manufacturing
  • CAR-T Lipid Nanoparticle Encapsulation
• CAR Viral Vector Packaging
  • CAR-T AAV Packaging
  • CAR-T Lentivirus Packaging
• CAR Cell CDMO
  • FIH CAR-T Manufacturing
  • IND Grade CAR-T Manufacturing
  • Clinical Grade CAR-T Manufacturing

The advent of Chimeric Antigen Receptor T-cell (CAR-T) therapies has revolutionized the field of oncology, providing new avenues for treating various forms of cancer. Our 20 years of experience in the biotechnology sector have equipped us with the expertise and technological capabilities to support the entire lifecycle of CAR-T products, from early development to commercialization.

• Support Knowledge
• Documents & Newsletters
• Webinars
• Podcasts
• Literature Reviews

Use the resources in our library to help you understand your options and make critical decisions for your study. We offer oncolytic virus, CAR-T, and dendritic cell related documents, as well as newsletter. If you don't find the answers you're looking for, contact us for additional assistance.

• Flyers
• Newsletter

• Distributors
• About Us
• Contact Us
• Careers
• Events

Get a real taste and understanding of the business and culture of one of the world's great research-based cellular and gene therapy discovery and development companies.